These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11450646)

  • 21. Monoclonal antibodies against Schistosoma mekongi surface tegumental antigens.
    Viyanant V; Gajanadana O; Upatham ES; Sobhon P; Kruatrachue M; Ahmed S; Ardseungnoen P
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):484-8. PubMed ID: 7512753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and characterization of monoclonal antibodies against human BAD protein.
    Afanassiev V; Troppmair J; Schuler M; Weber C; Rapp UR
    Hybridoma; 1998 Aug; 17(4):383-7. PubMed ID: 9790073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characterization of hybridomas producing monoclonal antibodies against human alpha interferon.
    Novák M; Borecký L; Kontseková E; Kontsek P; Nováková M
    Acta Virol; 1986 May; 30(3):228-33. PubMed ID: 2874727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two mouse hybridomas secreting monoclonal antibodies against human liver carcinoma and their antibody specificity].
    Xie H; Yang ZH; Chen RM; Yao Z; Wang BM; Guo SY; Yan ZF
    Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):263-70. PubMed ID: 2424200
    [No Abstract]   [Full Text] [Related]  

  • 25. Human monoclonal anti-Rh antibodies produced by human-mouse heterohybridomas express the Gal alpha 1-3 Gal epitope.
    Montaño RF; Romano EL
    Hum Antibodies Hybridomas; 1994; 5(3-4):152-6. PubMed ID: 7538807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of human-mouse hybridomas using lymphocytes from sterile women with sperm-immobilizing antibodies.
    Kyurkchiev SD; Shigeta M; Koyama K; Isojima S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2135-6. PubMed ID: 2416854
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
    White J; Haskins KM; Marrack P; Kappler J
    J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybridomas: a revolution in reagent production.
    Davie JM
    Pharmacol Rev; 1982 Mar; 34(1):115-8. PubMed ID: 6175985
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of human monoclonal antibodies against human cytomegalovirus.
    Kanoh Y; Yunoki M; Taniguchi T; Suzuki Y; Ideno S; Morita E; Hirama M; Yokoyama K; Yamanishi K
    Hybridoma; 1992 Oct; 11(5):569-79. PubMed ID: 1281135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periodate oxidation of R36A pneumococci greatly enhances production of hybridomas secreting anti-protein antibodies.
    Casal J; Jado I; Fenoll A; Perez A; Toraño A
    Microb Pathog; 1998 Feb; 24(2):111-6. PubMed ID: 9480793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and partial characterization of hybridoma clones secreting monoclonal antibodies against Francisella tularensis.
    Bhatti AR; Wong JP; Woods DE
    Hybridoma; 1993 Apr; 12(2):197-202. PubMed ID: 7686137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of hybridomas secreting monoclonal antibodies against C epsilon 2 and C epsilon 4 domains of human IgE.
    Ichimori Y; Kurokawa T; Ikeyama S; Sasada R; Tsukamoto K
    Hybridoma; 1985; 4(1):47-53. PubMed ID: 2578427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Human monoclonal antibodies with human-mouse hybridomas].
    Naoe T; Kato K; Shiku H; Yamada K
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte hybridomas: 1986.
    LeBlanc PA
    Year Immunol; 1988; 3():247-59. PubMed ID: 3327313
    [No Abstract]   [Full Text] [Related]  

  • 35. Monoclonal antibodies in nuclear medicine.
    Keenan AM; Harbert JC; Larson SM
    J Nucl Med; 1985 May; 26(5):531-7. PubMed ID: 2580961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential production of monoclonal antibodies to carbohydrate moiety or peptides moiety of glycoproteins by different routes of immunization.
    Kimura A; Nakashima R; Inoue H; Yasuda S; Ikemoto E; Nishimoto K; Tsuji T
    Hybridoma; 1998 Jun; 17(3):245-50. PubMed ID: 9708826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies against adenovirus type 5: preparation and preliminary characterization.
    Russell WC; Patel G; Precious B; Sharp I; Gardner PS
    J Gen Virol; 1981 Oct; 56(Pt 2):393-408. PubMed ID: 6171612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
    Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
    Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of Yersinia pseudotuberculosis surface antigen epitopes using monoclonal antibodies].
    Byvalov AA; Dudina LG; Litvinets SG; Novikova OD; Khomenko VA; Portniagina OIu; Ovodov IuS
    Prikl Biokhim Mikrobiol; 2014; 50(2):203-10. PubMed ID: 25272740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on hybridoma technology in radioimmunodetection and therapy.
    Stigbrand T
    Acta Chir Scand Suppl; 1989; 549():40-5. PubMed ID: 2648716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.